Undoctored vault view

Pharmac has funded upadacitinib tablets as an alternative treatment for New Zealanders with severe rheumatoid arthritis, who are impacted by the tocilizumab stock shortage

Pharmac is widening funded access to tocilizumab, an immunosuppressive drug used mainly to treat arthritis, to treat moderate to severe cases of COVID-19, subject to access criteria from 1 October 2021

Patient harm is common in New Zealand, but mostly not preventable, a new University of Otago study has found

Statement from Chief Coroner Judge Deborah Marshall on coronial cases being linked to COVID-19 vaccination

The Board of Directors (the Board) of the Pharmacy Guild of New Zealand (the Guild) has elected Des Bailey as President, and Anthony Roberts as Vice President

Medsafe and the Ministry of Health strongly recommends that ivermectin is not used for prevention or treatment of COVID-19

Pharmac is pleased to confirm that there will be no change in primidone tablets, a treatment used for the management of seizures and epilepsy

Pharmac has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New Zealand with product for the next three months, due to massive demand worldwide

New Zealand’s low vaccination rate can also be credited to late and lazy engagement with primary care providers such as pharmacies, says National’s Health spokesman Dr Shane Reti

Child Poverty Action Group is deeply concerned the Minister of Finance this week refused to signal what, if any, desperately-needed emergency income relief is on its way to vast numbers of low-income families playing their part in lockdown